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Abstract 
Actinomycosis is a rare chronic granulomatous infection caused by Gram-positive, non-acid-fast, anaerobic to microaerophilic 
bacteria.  
We report a case of cervicofacial actinomycosis in an 86-year-old woman undergoing immunosuppressive therapy with 
azathioprine and prednisone for rheumatoid arthritis. She underwent a dental treatment several months earlier.  The diagnosis of 
culture-negative actinomycosis was based on histolopathology findings and the isolation of companion bacteria. The patient was 
treated with amoxicillin-clavulanic acid for 3 months, which produced complete clearance of her cervicofacial actinomycosis.  
Our case points out the pitfalls of diagnostic procedures in actinomycosis and the ability of this rare disease to mimic other 
medical conditions.  
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Case synopsis 
An 86-year-old woman presented at our outpatient clinic with a one-month history of a progressive, painful swelling on the left 
cheek. She received oral amoxicillin-clavulanic acid 1g twice daily over 10 days, with little effect. The patient was in good health 
and constitutional symptoms were denied. Her medical history included rheumatoid arthritis, which was treated with azathioprine 
50mg/day and prednisolone 7.5mg/day. Any trauma to the cheek was denied, but she underwent a dental treatment a few months 
earlier. Clinically there was an indurated plaque, 5cm in diameter, with three red bluish nodules on the left cheek, some of which 
were ulcerated (Figure 1A). Cervical lymphadenopathy was not palpable.  
A skin biopsy was performed showing a deep inflammatory infiltrate and epithelial lamellas, which suggested the diagnosis of a 
ruptured epidermoid cyst.  There was no evidence of a malignant process. Histological stains for pathogens (PAS, Ziehl-Neelsen) 
were negative; Brenn-Brown stain revealed bacteria-like structures. Both broad spectrum bacterial PCR from the skin biopsy and 
aerobic and anaerobic tissue cultures were all negative. A cellular test for tuberculosis (QuantiFERON gold) was also negative. 
An MRI of the head suggested an inflammatory process of the soft tissue deriving from a maxillary sinus.  
Owing to growth of the skin lesion over the next four months the patient was referred for further investigations to our inpatient 
clinic.  Physical examination of the left cheek showed multiple, red-bluish, partially ulcerated nodules, which on pressure 
discharged purulent material.  In addition, an indurated, firm plaque measuring approximately 7cm in diameter was palpable 
(Figure 1B). The clinical differential diagnosis included a malignant process, an odontogenic fistula,  a disrupted epidermal cyst, 
cutaneous sarcoidosis, cutaneous tuberculosis with fistulae (scrofuloderma), or other deep infections. A deep skin biopsy was 
performed, which showed a massive dermal, predominantly neutrophilic infiltrate forming abscesses (Figure 1D). Sulfur granules 
appeared among the infiltrate (Figure 1d,e,f). Brown-Brenn staining revealed Gram-positive and PAS-positive filamentous, 
radially oriented structures at the periphery of these granules (Figure E,F). Bacterial cultures remained negative. Fusobacterium 
nucleatum and Porphyromonas gingivalis were detected by16S rDNA-broad spectrum PCR. Both bacteria are commonly found as 
bystander organisms in cervicofacial actinomycosis and finally enabled us to establish the diagnosis. 
The patient was started on intravenous amoxicillin-clavulanic acid (2,2g TID) for 2 weeks. After a significant clinical regression 
of the lesions, the therapy was changed to oral amoxicillin-clavulanic acid (625mg bid) for 10 weeks. Under this treatment all 
nodules and the firm subcutaneous plaque fully resolved, leaving only focal hyperpigmentation and discrete scars (Figure 1C).  
 
Figure 1. Clinical and histological presentation of cervicofacial actinomycosis: Panels A, B, C show the evolution of skin lesions over nine 
months (time points are marked). Panel D shows overview histology (upper left panel, hematoxylin and eosin staining, original magnification 
x0.6) and massive dermal inflammatory infiltrate consisting predominantly of neutrophils and round homogenous eosinophilic structures, 
known as sulfur bodies (hematoxylin and eosin staining, original magnification x4). Panels E and F reveal characteristic of sulfur bodies using 
different histological stains (H/E, hematoxylin and eosin staining, original magnification x10; B-B, Brenn-Brown staining, original 
magnification x10; PAS, periodic acid-schiff staining, original magnification x10).  
Comment 
Actinomycosis is a rare, chronic and slowly progressive infection caused by Gram-positive, non-acid-fast, anaerobic to 
microaerophilic bacteria. Owing to their filamentous structure Actinomyces were originally considered fungi. Actinomyces are 
commensals of the human oropharyngeal, respiratory, gastrointestinal, and urogenital tracts. Cervicofacial actinomycosis, also 
called “lumpy jaw syndrome,” is the most common form caused by Actinomyces israelii and comprises about 50% of all reported 
cases [1,2] It usually follows dental treatments, although it can arise spontaneously in patients with poor dental hygiene. 
Actinomycosis is clinically often misdiagnosed because it can mimic numerous infectious and non-infectious diseases, including 
malignant tumors. The typical presentation of cervicofacial actinomycosis is a painless or painful soft tissue swelling. Direct 
spread into the adjacent tissue can develop over time, along with development of fistulas that discharge purulent material 
containing typical yellow sulfur granules. Other variants of actinomycosis include thoracic, abdominopelvic, central nervous 
system, musculoskeletal, and disseminated infection. Even though actinomycosis is not considered an opportunistic infection, it 
has been described in individuals with impaired immune systems, as in HIV disease or leukemia [3, 4]. There is no predilection 
for age, race, season or occupation. 
Diagnosis of actinomycosis requires correlation of histopathological and microbiologic findings. The cornerstone of the 
histological diagnosis of actinomycosis is the presence of the so-called “sulfur granules” or Splendore-Hoeppli phenomenon 
(Figure histology) in crumbly, pus-resembling secretions [5]. Sulfur granules are bacterial colonies that appear as round or oval 
eosinophilic masses with basophilic terminal “clubs” on hematoxylin-eosin stained sections. However, sulfur granules are not 
specific for actinomycosis because they represent a localized immunologic response to an antigen-antibody precipitation occurring 
in infectious (e.g. fungi, parasites and bacteria) or other non-infectious processes (e.g. around inert material, in hypereosinophilic 
syndrome and allergic conjunctival granuloma) [6]. Direct isolation of actinomyces from a clinical specimen or from sulfur 
granules is necessary for a definitive diagnosis. However, the failure rate for isolation via anaerobic culture is high owing to 
previous antibiotic treatment, inadequate methodology, or overgrowth of the slow growing actinomyces by bystander organisms 
like Bacteroides, Fusobacteriumn, or Aggregatibacter [2].  Fusobacterium nucleatum and Porphyromonas gingivalis are oral 
bacteria indigenous to the human oral cavity, which are common bystander bacteria of cervicofacial actinomycosis. Because 
sequencing of the 16S rDNA gene has become a reference method for bacterial identification [7],  it also became possible to 
identify such bystander bacteria that are difficult to cultivate. In our patient, the results of 16S rDNA gene amplification and 
sequencing were negative for Actinomyces spp., but Fusobacterium nucleatum and Porphyromonas gingivalis could be sequenced. 
This constellation of findings supported the diagnosis of actinomycosis, without direct detection of actinomyces.    
Actinomyces spp. are sensitive to penicillin and this antibiotic represents the first line treatment [1, 2]. Penicillin G is the drug of 
choice for treating actinomycosis and development of resistance during prolonged therapy is rare. The combination of penicillin 
and a beta-lactamase inhibitor offers the advantage of treating the beta-lactamase producing bystander organisms as well. The 
antibiotic regimen should initially be administered intravenously until clinical improvement is demonstrated, followed by oral 
administration over 2–12 months. The patients’ response to therapy indicates the duration of treatment. Surgery is only necessary 
in cases with formation of necrotic tissue, soft tissue abscesses requiring drainage, or excessive scar and fistula formation. The 
prognosis for treated cervicofacial actinomycosis is excellent [3]. 
In conclusion, we report a case of actinomycosis in which the diagnosis was established by combining histopathology findings and 
the isolation of companion bacteria, without direct isolation of Actinomyces spp.  Our case points out the pitfalls of the diagnosis 
of actinomycosis.  Physicians should be aware of the many faces of actinomycosis and the difficulty of detecting Actinomyces in 
clinical samples.  
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